• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    Amendment: SEC Form SCHEDULE 13G/A filed by IBEX Limited

    2/14/25 8:41:50 AM ET
    $IBEX
    EDP Services
    Technology
    Get the next $IBEX alert in real time by email



    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549


    SCHEDULE 13G


    UNDER THE SECURITIES EXCHANGE ACT OF 1934
    (Amendment No. 4)


    IBEX Limited

    (Name of Issuer)


    Common Stock

    (Title of Class of Securities)


    G4690M101

    (CUSIP Number)


    12/31/2024

    (Date of Event Which Requires Filing of this Statement)


    Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
    Checkbox checked   Rule 13d-1(b)
    Checkbox not checked   Rule 13d-1(c)
    Checkbox not checked   Rule 13d-1(d)






    SCHEDULE 13G

    CUSIP No.
    G4690M101


    1Names of Reporting Persons

    American Century Capital Portfolios, Inc.
    2Check the appropriate box if a member of a Group (see instructions)

    Checkbox not checked  (a)
    Checkbox not checked  (b)
    3Sec Use Only
    4Citizenship or Place of Organization

    MARYLAND
    Number of Shares Beneficially Owned by Each Reporting Person With:
    5Sole Voting Power

    545,493.00
    6Shared Voting Power

    7Sole Dispositive Power

    545,493.00
    8Shared Dispositive Power

    9Aggregate Amount Beneficially Owned by Each Reporting Person

    545,493.00
    10Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

    Checkbox not checked
    11Percent of class represented by amount in row (9)

    3.2 %
    12Type of Reporting Person (See Instructions)

    IV


    SCHEDULE 13G

    CUSIP No.
    G4690M101


    1Names of Reporting Persons

    American Century Investment Management, Inc.
    2Check the appropriate box if a member of a Group (see instructions)

    Checkbox not checked  (a)
    Checkbox not checked  (b)
    3Sec Use Only
    4Citizenship or Place of Organization

    DELAWARE
    Number of Shares Beneficially Owned by Each Reporting Person With:
    5Sole Voting Power

    918,418.00
    6Shared Voting Power

    7Sole Dispositive Power

    944,703.00
    8Shared Dispositive Power

    9Aggregate Amount Beneficially Owned by Each Reporting Person

    944,703.00
    10Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

    Checkbox not checked
    11Percent of class represented by amount in row (9)

    5.6 %
    12Type of Reporting Person (See Instructions)

    IA


    SCHEDULE 13G

    CUSIP No.
    G4690M101


    1Names of Reporting Persons

    American Century Companies, Inc.
    2Check the appropriate box if a member of a Group (see instructions)

    Checkbox not checked  (a)
    Checkbox not checked  (b)
    3Sec Use Only
    4Citizenship or Place of Organization

    DELAWARE
    Number of Shares Beneficially Owned by Each Reporting Person With:
    5Sole Voting Power

    918,418.00
    6Shared Voting Power

    7Sole Dispositive Power

    944,703.00
    8Shared Dispositive Power

    9Aggregate Amount Beneficially Owned by Each Reporting Person

    944,703.00
    10Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

    Checkbox not checked
    11Percent of class represented by amount in row (9)

    5.6 %
    12Type of Reporting Person (See Instructions)

    HC


    SCHEDULE 13G

    CUSIP No.
    G4690M101


    1Names of Reporting Persons

    Stowers Institute for Medical Research
    2Check the appropriate box if a member of a Group (see instructions)

    Checkbox not checked  (a)
    Checkbox not checked  (b)
    3Sec Use Only
    4Citizenship or Place of Organization

    DELAWARE
    Number of Shares Beneficially Owned by Each Reporting Person With:
    5Sole Voting Power

    918,418.00
    6Shared Voting Power

    7Sole Dispositive Power

    944,703.00
    8Shared Dispositive Power

    9Aggregate Amount Beneficially Owned by Each Reporting Person

    944,703.00
    10Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

    Checkbox not checked
    11Percent of class represented by amount in row (9)

    5.6 %
    12Type of Reporting Person (See Instructions)

    HC


    SCHEDULE 13G

    Item 1. 
    (a)Name of issuer:

    IBEX Limited
    (b)Address of issuer's principal executive offices:

    1717 Pennsylvania Avenue NW, Suite 825, Washington, DC, 20006
    Item 2. 
    (a)Name of person filing:

    American Century Capital Portfolios, Inc. American Century Investment Management, Inc. American Century Companies, Inc. Stowers Institute for Medical Research
    (b)Address or principal business office or, if none, residence:

    4500 Main Street 9th Floor Kansas City, Missouri 64111
    (c)Citizenship:

    Maryland Delaware
    (d)Title of class of securities:

    Common Stock
    (e)CUSIP No.:

    G4690M101
    Item 3.If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
    (a)Checkbox not checked   Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
    (b)Checkbox not checked   Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
    (c)Checkbox not checked   Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
    (d)Checkbox checked   Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
    (e)Checkbox checked   An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
    (f)Checkbox not checked   An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
    (g)Checkbox checked   A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
    (h)Checkbox not checked   A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
    (i)Checkbox not checked   A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
    (j)Checkbox not checked   A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J),
           please specify the type of institution:
    (k)Checkbox not checked   Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
     
    Item 4.Ownership
    (a)Amount beneficially owned:

    See the response(s) to Item 9 on the attached cover page(s).
    (b)Percent of class:

    See the response(s) to Item 11 on the attached cover page(s).
    (c)Number of shares as to which the person has:
     (i) Sole power to vote or to direct the vote:

    See the response(s) to Item 5 on the attached cover page(s).

     (ii) Shared power to vote or to direct the vote:

    See the response(s) to Item 6 on the attached cover page(s).

     (iii) Sole power to dispose or to direct the disposition of:

    See the response(s) to Item 7 on the attached cover page(s).

     (iv) Shared power to dispose or to direct the disposition of:

    See the response(s) to Item 8 on the attached cover page(s).

    Item 5.Ownership of 5 Percent or Less of a Class.
     
    Item 6.Ownership of more than 5 Percent on Behalf of Another Person.
     
    If any other person is known to have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, such securities, a statement to that effect should be included in response to this item and, if such interest relates to more than 5 percent of the class, such person should be identified. A listing of the shareholders of an investment company registered under the Investment Company Act of 1940 or the beneficiaries of employee benefit plan, pension fund or endowment fund is not required.


    Various persons, including the investment companies and separate institutional investor accounts that American Century Investment Management, Inc. ("ACIM") serves as investment adviser, have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, the securities that are the subject of this schedule. Except as may be otherwise indicated if this is a joint filing, not more than 5% of the class of securities that is the subject of this schedule is owned by any one client advised by ACIM.
    Item 7.Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
     
    If a parent holding company has filed this schedule, pursuant to Rule 13d-1(b)(ii)(G), so indicate under Item 3(g) and attach an exhibit stating the identity and the Item 3 classification of the relevant subsidiary. If a parent holding company has filed this schedule pursuant to Rule 13d-1(c) or Rule 13d-1(d), attach an exhibit stating the identification of the relevant subsidiary.


    This Item identifies each subsidiary of American Century Companies, Inc. ("ACC"), which is controlled by the Stowers Institute for Medical Research, that is a beneficial owner of securities that are subject of this schedule (the "Subject Securities"). American Century Investment Management, Inc. ("ACIM") is a wholly-owned subsidiary of ACC and an investment adviser registered under Section 203 of the Investment Advisers Act of 1940.
    Item 8.Identification and Classification of Members of the Group.
     
    If a group has filed this schedule pursuant to §240.13d-1(b)(1)(ii)(J), so indicate under Item 3(j) and attach an exhibit stating the identity and Item 3 classification of each member of the group. If a group has filed this schedule pursuant to §240.13d-1(c) or §240.13d-1(d), attach an exhibit stating the identity of each member of the group.


    Not applicable
    Item 9.Notice of Dissolution of Group.
     
    Notice of dissolution of a group may be furnished as an exhibit stating the date of the dissolution and that all further filings with respect to transactions in the security reported on will be filed, if required, by members of the group, in their individual capacity. See Item 5.


    Not applicable

    Item 10.Certifications:
     
    By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11.

        SIGNATURE 
     
    After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

     
    American Century Capital Portfolios, Inc.
     
    Signature:American Century Capital Portfolios, Inc.
    Name/Title:/s/ John Pak / Senior Vice President
    Date:02/14/2025
     
    American Century Investment Management, Inc.
     
    Signature:American Century Investment Management, Inc.
    Name/Title:/s/ John Pak / Senior Vice President
    Date:02/14/2025
     
    American Century Companies, Inc.
     
    Signature:American Century Companies, Inc.
    Name/Title:/s/ John Pak / Senior Vice President
    Date:02/14/2025
     
    Stowers Institute for Medical Research
     
    Signature:Stowers Institute for Medical Research
    Name/Title:/s/ Richard W. Brown / Chairman
    Date:02/14/2025
    Exhibit Information

    EXHIBIT Each of the undersigned hereby agrees and consents to the execution and joint filing on its behalf by American Century Investment Management, Inc. of this Schedule 13G respecting the beneficial ownership of the securities which are the subject of this schedule. Dated this 14th day of February, 2025. AMERICAN CENTURY CAPITAL PORTFOLIOS, INC. ("ACCP") AMERICAN CENTURY INVESTMENT MANAGEMENT, INC. ("ACIM") AMERICAN CENTURY COMPANIES, INC. ("ACC") By: _/s/ John Pak_________________ John Pak Senior Vice President, ACCP, ACIM and ACC STOWERS INSTITUTE FOR MEDICAL RESEARCH, solely in its capacity as control entity of ACC By: _/s/ Richard W. Brown___________ Richard W. Brown Chairman

    Get the next $IBEX alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $IBEX

    DatePrice TargetRatingAnalyst
    5/12/2025$30.00Outperform → Neutral
    Robert W. Baird
    11/10/2023$17.00Overweight → Neutral
    Piper Sandler
    9/14/2023$27.00 → $18.00Outperform → Sector Perform
    RBC Capital Mkts
    7/19/2022$20.00Buy → Neutral
    Citigroup
    2/17/2022$18.00 → $20.00Overweight
    Piper Sandler
    1/13/2022$21.00 → $18.00Overweight
    Piper Sandler
    11/24/2021$23.00 → $21.00Buy
    Citigroup
    11/23/2021$24.00 → $22.00Outperform
    RBC Capital
    More analyst ratings

    $IBEX
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • ibex Launches the 2025 CX Leadership Awards

      WASHINGTON, May 21, 2025 (GLOBE NEWSWIRE) -- ibex (NASDAQ:IBEX), the leading global provider of business process outsourcing (BPO) and AI-powered CX solutions, today kicked off the 2025 CX Leadership Awards, which honor the top customer experience (CX) innovators, leaders, and contributors around the world. This year's CX Leadership Award nominees, selected from an ultra-competitive roster of renowned CX experts and visionaries, will be announced over the coming weeks. Winners will be crowned on June 11, 2025 at the ibex CX Leaders Dinner in Las Vegas during Customer Contact Week (CCW). "As the AI-powered CX leader, ibex is pleased to congratulate the 2025 CX Leadership Award nominees fo

      5/21/25 9:00:00 AM ET
      $IBEX
      EDP Services
      Technology
    • ibex Wave iX Wins Gold Stevie® Award at The 23rd Annual American Business Awards®

      WASHINGTON, May 14, 2025 (GLOBE NEWSWIRE) -- ibex (NASDAQ:IBEX), a leading global provider of business process outsourcing (BPO) and AI-powered customer engagement technology solutions, today announced that ibex Wave iX has earned the Gold Stevie® Award in the Achievement in Technology Innovation category for The 23rd Annual American Business Awards®. This honor emphasizes the success of ibex's AI-powered Wave iX solution platform in transforming the customer experience for leading brands around the world. "We are proud to be recognized by The Stevie® Awards for The Annual American Business Awards®," said Carl O'Neil, EVP and GM of Wave iX, Augment, and ibex CX. "AI is transforming the cu

      5/14/25 9:00:00 AM ET
      $IBEX
      EDP Services
      Technology
    • IBEX Reports Record Quarterly Revenue and EPS, Returns to Double-Digit Growth, Raises Fiscal Year Guidance

      Quarterly revenue grew 11% versus prior year quarter - highest growth in ten quartersAdjusted EPS of $0.82 - an increase of 18% to prior year quarterMakes strategic entry into India - launching with leading healthcare clientBoard authorizes a new $15 million share repurchase plan WASHINGTON, May 08, 2025 (GLOBE NEWSWIRE) -- IBEX Limited ("ibex"), a leading provider in global business process outsourcing and end-to-end customer engagement technology solutions, today announced financial results for its third fiscal quarter ended March 31, 2025.  Three months ended March 31, 2025 Nine months ended March 31, 2025($ millions, except per share amounts) 2025   2024  Change  2025   2024  ChangeRe

      5/8/25 4:05:00 PM ET
      $IBEX
      EDP Services
      Technology

    $IBEX
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • IBEX Ltd. downgraded by Robert W. Baird with a new price target

      Robert W. Baird downgraded IBEX Ltd. from Outperform to Neutral and set a new price target of $30.00

      5/12/25 8:21:23 AM ET
      $IBEX
      EDP Services
      Technology
    • IBEX Ltd. downgraded by Piper Sandler with a new price target

      Piper Sandler downgraded IBEX Ltd. from Overweight to Neutral and set a new price target of $17.00

      11/10/23 7:31:30 AM ET
      $IBEX
      EDP Services
      Technology
    • IBEX Ltd. downgraded by RBC Capital Mkts with a new price target

      RBC Capital Mkts downgraded IBEX Ltd. from Outperform to Sector Perform and set a new price target of $18.00 from $27.00 previously

      9/14/23 7:19:17 AM ET
      $IBEX
      EDP Services
      Technology

    $IBEX
    Leadership Updates

    Live Leadership Updates

    See more
    • ibex Names Phil Taylor Country Manager for Jamaica

      KINGSTON, Jamaica, Feb. 12, 2025 (GLOBE NEWSWIRE) -- ibex (NASDAQ:IBEX), a leading global provider of business process outsourcing (BPO) and AI-powered customer engagement technology solutions, today announced the appointment of Phil Taylor as Senior Vice President and Country Manager for Jamaica. In his new role, Phil will report directly to David Wilkerson, Executive Vice President of Global Operations, and will oversee the company's operations and strategic initiatives in Jamaica. Phil joined ibex two years ago as Vice President of Operations and has since become an integral part of the organization. With over 20 years of experience in the contact center industry, Phil has built a re

      2/12/25 9:00:00 AM ET
      $IBEX
      EDP Services
      Technology
    • ibex Appoints Karen Batungbacal to Board of Directors

      WASHINGTON, Jan. 06, 2025 (GLOBE NEWSWIRE) -- IBEX Limited ("ibex"), a leading provider in global business process outsourcing and end-to-end customer engagement technology solutions, today announced the appointment of Karen Batungbacal to its Board of Directors. Batungbacal will begin her official duties as a board member on January 20, 2025. "We are excited to welcome Karen to our Board of Directors," said Bob Dechant, Board Member and Chief Executive Officer of ibex Limited. "As we continue to pursue our strategy to redefine customer experience (CX) with AI and further grow in key vertical markets and geographies, Karen is the ideal partner to help guide our growth as we scale efficien

      1/6/25 9:00:00 AM ET
      $IBEX
      EDP Services
      Technology
    • ibex CTO Andreas Wilkens to Join Distinguished Panel on AI Ethics and Business Innovation

      WASHINGTON, Nov. 20, 2024 (GLOBE NEWSWIRE) -- ibex (NASDAQ:IBEX), a leading global provider of business process outsourcing (BPO) and AI-powered customer engagement technology solutions, today announced that ibex Chief Technology Officer Andreas Wilkens will join industry leaders from SAP, Google, and Microsoft for a high-level panel discussion on ethical AI implementation in business. The panel – AI for Competitive Edge: Balancing Innovation and Ethics for Growth – will be hosted by SAP in Bellevue, Wash. on Thursday, November 21, 2024. The panel, which will be moderated by Monika Sengul-Jones of the University of Washington, will discuss critical themes including Bias and Fairness, Priv

      11/20/24 9:00:00 AM ET
      $IBEX
      EDP Services
      Technology

    $IBEX
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Chief Sales and CS Officer Dawson Bruce Neil exercised 10,000 shares at a strike of $12.75 and sold $244,800 worth of shares (10,000 units at $24.48) (SEC Form 4)

      4 - IBEX Ltd (0001720420) (Issuer)

      5/16/25 5:15:39 PM ET
      $IBEX
      EDP Services
      Technology
    • Chief Executive Officer Dechant Robert Thomas exercised 49,931 shares at a strike of $12.75 and sold $1,310,189 worth of shares (49,931 units at $26.24) (SEC Form 4)

      4 - IBEX Ltd (0001720420) (Issuer)

      2/27/25 4:54:14 PM ET
      $IBEX
      EDP Services
      Technology
    • Director Khaishgi Mohammedulla sold $322,237 worth of shares (12,600 units at $25.57), decreasing direct ownership by 14% to 77,312 units (SEC Form 4)

      4 - IBEX Ltd (0001720420) (Issuer)

      2/21/25 4:37:48 PM ET
      $IBEX
      EDP Services
      Technology

    $IBEX
    Financials

    Live finance-specific insights

    See more
    • IBEX Reports Record Quarterly Revenue and EPS, Returns to Double-Digit Growth, Raises Fiscal Year Guidance

      Quarterly revenue grew 11% versus prior year quarter - highest growth in ten quartersAdjusted EPS of $0.82 - an increase of 18% to prior year quarterMakes strategic entry into India - launching with leading healthcare clientBoard authorizes a new $15 million share repurchase plan WASHINGTON, May 08, 2025 (GLOBE NEWSWIRE) -- IBEX Limited ("ibex"), a leading provider in global business process outsourcing and end-to-end customer engagement technology solutions, today announced financial results for its third fiscal quarter ended March 31, 2025.  Three months ended March 31, 2025 Nine months ended March 31, 2025($ millions, except per share amounts) 2025   2024  Change  2025   2024  ChangeRe

      5/8/25 4:05:00 PM ET
      $IBEX
      EDP Services
      Technology
    • IBEX Limited to Announce Third Quarter 2025 Financial Results on May 8th, 2025

      WASHINGTON, April 24, 2025 (GLOBE NEWSWIRE) -- IBEX Limited ("ibex") (NASDAQ:IBEX), a leading global provider of business process outsourcing (BPO) and customer engagement technology solutions, today announced it will report third quarter 2025 financial results after the market close on Thursday, May 8, 2025. Management will host a conference call and webcast to discuss the Company's financial results, recent developments, and business outlook at 4:30 p.m. ET. What:IBEX Limited Announces Third Quarter 2025 Financial ResultsWhen:Thursday, May 8, 2025Time:4:30 p.m. ETLive Call:Register Here for Dial-In and PINWebcast:https://investors.ibex.co/   About ibexibex delivers innovative business pr

      4/24/25 4:30:00 PM ET
      $IBEX
      EDP Services
      Technology
    • IBEX Reports Record Quarterly Revenue and Strong EPS

      Quarterly revenue grew 6.1% versus prior year quarter - highest growth in 9 quartersStrong adjusted EBITDA margin expansion year-over-year - 10 out of the last 11 quarters Adjusted EPS of $0.59 - an increase of 36% to prior year quarterRaises guidance on revenue and lower end of EBITDA rangeRepurchased approximately 3.6 million shares from TRGI during the second quarter of fiscal year 2025, representing 21% of our shares outstanding and eliminating controlled company status WASHINGTON, Feb. 06, 2025 (GLOBE NEWSWIRE) -- IBEX Limited ("ibex"), a leading provider in global business process outsourcing and end-to-end customer engagement technology solutions, today announced financial resu

      2/6/25 4:05:00 PM ET
      $IBEX
      EDP Services
      Technology

    $IBEX
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • Amendment: SEC Form SC 13D/A filed by IBEX Limited

      SC 13D/A - IBEX Ltd (0001720420) (Subject)

      12/6/24 7:28:26 PM ET
      $IBEX
      EDP Services
      Technology
    • Amendment: SEC Form SC 13D/A filed by IBEX Limited

      SC 13D/A - IBEX Ltd (0001720420) (Subject)

      11/22/24 4:17:06 PM ET
      $IBEX
      EDP Services
      Technology
    • Amendment: SEC Form SC 13G/A filed by IBEX Limited

      SC 13G/A - IBEX Ltd (0001720420) (Subject)

      11/8/24 9:16:21 AM ET
      $IBEX
      EDP Services
      Technology

    $IBEX
    SEC Filings

    See more
    • SEC Form 10-Q filed by IBEX Limited

      10-Q - IBEX Ltd (0001720420) (Filer)

      5/8/25 4:24:58 PM ET
      $IBEX
      EDP Services
      Technology
    • IBEX Limited filed SEC Form 8-K: Results of Operations and Financial Condition, Other Events, Financial Statements and Exhibits

      8-K - IBEX Ltd (0001720420) (Filer)

      5/8/25 4:20:07 PM ET
      $IBEX
      EDP Services
      Technology
    • Amendment: SEC Form SCHEDULE 13G/A filed by IBEX Limited

      SCHEDULE 13G/A - IBEX Ltd (0001720420) (Subject)

      5/5/25 2:03:05 PM ET
      $IBEX
      EDP Services
      Technology